Development of lapatinib nanosponges for enhancing bioavailability
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference55 articles.
1. Lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer: a systematic review;Madden;Int. J. Clin. Pharm. Ther.,2018
2. Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence;Segovia-Mendoza;Am. J. Cancer Res.,2015
3. Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib;Teng;Mol. Pharmacol.,2010
4. Reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2;Dai;Canc. Res.,2008
5. Incorporation of lapatinib into human serum albumin nanoparticles with enhanced anti-tumor effects in HER2-positive breast cancer;Wan;Colloids Surf. B Biointerfaces,2015
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer Therapy;Current Medicinal Chemistry;2024-02
2. Nanosponge hydrogel of octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate of Alcaligenes faecalis;Applied Microbiology and Biotechnology;2024-01-12
3. Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics;International Journal of Pharmaceutics;2024-01
4. Nanocrystalline solid dispersions: an emerging approach for oral bioavailability enhancement of anticancer drugs using lapatinib ditosylate as the case drug;Journal of Dispersion Science and Technology;2023-11-25
5. Nanosponges as an Emerging Platform for Cancer Treatment and Diagnosis;Advanced Functional Materials;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3